Alexander Johnstone MacKay

Alexander MacKay practices at Icare Health Surgical Suites LLC in Bedford, Texas.

Alexander MacKay's NPI, 1750813226, was assigned on April 3, 2017. Alexander MacKay graduated from Paul L. Foster School of Medicine in 2017. Alexander MacKay holds Texas license T5615.

Alexander MacKay's primary practice is Icare Health Surgical Suites LLC, at 1604 Hospital Pkwy, Bedford, TX 76022 in Tarrant County. The practice phone is (682) 688-2020.

Alexander MacKay's primary practice is Icare Health Surgical Suites LLC in Bedford, Texas. Alexander MacKay is also affiliated with Texas Health Harris Methodist Hospital Hurst-Euless-Bedford. The medical group on file is Urology Partners of North Texas. Dmand AI also links Alexander MacKay to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexander MacKay practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Alexander MacKay's primary specialty in the NPI Registry, under taxonomy code 208800000X. Alexander MacKay is board certified in urology by the American Board of Urology. Alexander MacKay is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, pelvic prolapse and urinary endoscopy among the conditions Alexander MacKay treats.

CMS data shows 2,547 Medicare services from Alexander MacKay across 31 procedure codes in 2024, for 359 Medicare patients. Medicare paid $108,757 for them.

CMS counts 359 Medicare patients who saw Alexander MacKay in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Alexander MacKay's median patient age at 67, with 29% women.

In 2024, Alexander MacKay wrote 1,088 Medicare Part D claims for 313 patients. 79% of them were for generic drugs. CMS names the drug for 971 of them, across 21 drugs with 11 or more claims each, at $162,713 in total drug cost. In 2023, CMS named 576 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Alexander MacKay for performance year 2024, reported as part of a group. Alexander MacKay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexander MacKay as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Alexander MacKay in 2021. 2021 was the busiest year, with 2. Alexander MacKay's most frequent co-authors are Timothy Bolton Boone, MD, PhD, Furkan Dursun, MD and Rose Khavari, MD.

CMS Open Payments shows 97 general payments to Alexander MacKay from 30 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $531.

Alexander MacKay graduated from Paul L. Foster School of Medicine in 2017.

Alexander MacKay is in network with 21 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.